Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 3No longer available 2Completed 2Active not recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 339Neoplasms, Plasma Cell 62Lymphoma 38Recurrence 27Leukemia 26Lymphoma, Non-Hodgkin 21Leukemia, Myeloid, Acute 20Hodgkin Disease 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Myelodysplastic Syndromes 17Leukemia, Lymphocytic, Chronic, B-Cell 17Lymphoma, Follicular 16Lymphoma, Large B-Cell, Diffuse 15Immunoglobulin Light-chain Amyloidosis 14Lymphoma, B-Cell, Marginal Zone 13Hematologic Neoplasms 13Lymphoma, Mantle-Cell 12Burkitt Lymphoma 12Lymphoma, Large-Cell, Immunoblastic 10Neoplasms 8Myeloproliferative Disorders 8Leukemia, Myeloid, Chronic-Phase 8Leukemia, Myeloid, Accelerated Phase 8Blast Crisis 8Neoplasm, Residual 7Hematologic Diseases 7Pancreatic Neoplasms 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, B-Cell 6Lung Neoplasms 6

Interventions

Crizotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Granuloma, Plasma Cell × Plasma cell × Clear all
NCT03874273 2019-03-14

Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 2/3 Unknown
25 enrolled
Plasma cell

Granuloma, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡